updat estim exclud
follow manag present week updat
estim exclud tweak number base updat
outlook model ep compar
prior estim includ contribut in-lin
prior estim exclud compar consensu
estim appear includ esrx con
report consensu updat outlook
addit new member growth compar
averag growth new membership past though note
expect chang throughout year
valuat continu compel reiter ow
estim continu see signific upsid share trade
discount peer histor valuat exhibit catalyst
earn full guidanc
healthcar facil manag unit state
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
esrx cost revenu synergi
amort acquir intang asset net
special item incl addit amort esrx deal
incom continu oper
premium fee
incom tax
incom continu oper
valuat methodolog risk
assign price target ci calcul price target appli price-to-earnings
multipl line year averag base case ep
discount back vertic integr come signific cash flow
gener acquisit bring addit new capabl specialti pharmaci
increasingli larg spend beyond vertic integr play combin
expect gener signific cash flow help compani de-lev
month post close base case price-to-earnings multipl in-line year averag
also appropri multipl compar peer
risk price risk price target includ continu
challeng group disabl life segment slowdown global
supplement segment esrx deal integr fail meet synergi target
signific deploy balanc sheet larg mco/pbm compet
pbm busi come on-line pbm margin significantli contract
